Simple fecal test could help detect colorectal and pancreatic cancers

Tadashi Fujii, Associate Professor, Department of Medical Research on Prebiotics and Probiotics, Fujita Health University, JapanOur findings suggest that a common fecal microbial panel can produce different disease-specific signatures for CRC and PC. The results also raise the possibility that fecal qPCR could provide complementary information without invasive sampling."

"Ultimately, we hope this type of testing can become a simple first-step assessment that helps determine which individuals may need further clinical examination and the appropriate timing for follow-up," said Dr. Fujii. "Earlier identification of cancer or precancerous changes could help guide timely intervention, reduce unnecessary invasive testing, and potentially improve outcomes and quality of life."

Source:

Fujita Health University

Journal reference: